Cargando…
Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer
BACKGROUND: Mounting evidence has confirmed that peroxisome proliferator-activated receptors (PPARs) played a crucial role in the development and progression of bladder cancer (BLCA). The purpose of this study is to comprehensively investigate the function and prognostic value of PPAR-targeted genes...
Autores principales: | Zhu, Ke, Deng, Wen, Deng, Hui, Liu, Xiaoqiang, Wang, Gongxian, Fu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749226/ https://www.ncbi.nlm.nih.gov/pubmed/35027921 http://dx.doi.org/10.1155/2021/7056506 |
Ejemplares similares
-
Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
por: Zhu, Ke, et al.
Publicado: (2021) -
Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer
por: Zhu, Ke, et al.
Publicado: (2022) -
Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer
por: Zhu, Ke, et al.
Publicado: (2021) -
Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer
por: Li, Sheng, et al.
Publicado: (2023) -
Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
por: Jiang, Minxiao, et al.
Publicado: (2021)